Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy (Q46881201)
Jump to navigation
Jump to search
scientific article published on 26 November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy |
scientific article published on 26 November 2007 |
Statements
1 reference
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy (English)
1 reference
Hagop Kantarjian
1 reference
William Wierda
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Michael Keating
1 reference
Xuelin Huang
1 reference
Todd Riehl
1 reference
Jeffrey Tarrand
1 reference
Brandi O'Neal
1 reference
26 November 2007
1 reference
1 reference
111
1 reference
4
1 reference
1816-1819
1 reference
Identifiers
1 reference
1 reference